Mayo has launched a new company focused on predicting diseases before they occur. This effort involves analyzing genetic, molecular, and clinical data. A large dataset of 1 million people will be used to assist in this analysis, which will be aided by artificial intelligence.

The goal of this initiative is to enable earlier treatments and preventive solutions for various diseases. By leveraging AI-assisted analysis, the company aims to unlock new possibilities for disease prevention and treatment.

Further details about this new company and its objectives can be found through the source publication, which provides more information on this development.